China Resources Pharmaceutical's subsidiary CR Sanjiu's annual net profit increased by 1.6% to 3.421 billion RMB

China Resources Pharmaceutical (03320.HK) announced that its subsidiary China Resources Sanjiu (000999.SZ) reported an annual revenue of RMB 31.603 billion for the year ending December last year, an increase of 14.4% year-on-year. The net profit was RMB 3.421 billion, up 1.58% year-on-year; the net profit excluding non-recurring items was RMB 3.134 billion, an increase of 0.5% year-on-year; earnings per share were RMB 2.06. A cash dividend of 59 cents per share (before tax) will be distributed to all shareholders of China Resources Sanjiu